Um wow ok, this is incredibly early from them. I assume they've pushed this to the start of the month to try and capture any new eyes from yesterday's Innovation Nation TV piece.
Besides that surprise, a quick skim didn't highlight anything new for the long term holders. However unfortunately there's another decline on the Quarter-on-Quarter cash receipts: FY24-Q1 = $898k FY24-Q2 = $896k FY24-Q3 = $645k
What we were hoping was just a blip over the festive period and a slow-down on surgeries in that time, hasn't recovered. I'm not sure if there's a lag on receipts and this quarter's $645k is actually reflective of the Christmas period? Maybe next quarter we'll see this recover. Maybe... Lots of "ramping up" of sales being described in the quarterly again, with no ramping up of receipts to show for it.
Bigger things to come towards the end of the year, patience required again.
OCC Price at posting:
41.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)